von Willebrand factor‐collagen binding activity is increased in newborns and infants

ABSTRACT. von Willebrand factor (vWF) antigen (vWF:Ag) and vWF‐collagen binding activity (vWF:CBA) were measured in plasma by parallel quantitative ELISAs in normal newborns and infants (n=71). The medians for vWF:Ag (IUjml) and vWF:CBA (Ujml), respectively, were 1.46 and 1.91 for 2‐7 day‐old (n= 43), 1.22 and 1.40 for 2‐4 week‐old (n= 14), 1.22 and 1.15 for 2‐6‐month‐old (n= 14) infants and 0.98 and 1.08 (n= 36) in normal adults. Elevated levels of vWF:Ag, but particularly vWF:CBA were seen for up to 4 weeks of life reaching adult levels between 2 and 6 months of life. The elevated levels of the vWF parameters indicate that caution should be exercised when interpreting laboratory data and diagnosing von Willebrand disease in newborns and young infants and warrant the use of age‐specific reference ranges. The efficient haemostasis observed during early neonatal life may in part be due to the increased ability of vWF to interact with collagen.

[1]  U. Budde,et al.  Ein einfacher Test für die Bestimmung der Funktion des Von-Willebrand-Faktors: die Kollagenbindungsaktivität , 1994 .

[2]  E. Favaloro,et al.  von Willebrand's disease: Use of collagen binding assay provides potential improvement to laboratory monitoring of desmopressin (DDAVP) therapy , 1994, American journal of hematology.

[3]  C. Mazurier,et al.  Electrophoretic and functional characteristics of the von Willebrand factor in human fetal plasma , 1992, British Journal of Haematology.

[4]  E. Favaloro,et al.  Development of a simple collagen based ELISA assay aids in the diagnosis of, and permits sensitive discrimination between Type I and Type II, von Willebrand's disease , 1991, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[5]  W. Künzer,et al.  Hämostase der Neugeborenen , 1990 .

[6]  I. Witt,et al.  Das Protein-C-System bei Kindern , 1990 .

[7]  J. Moake,et al.  Relationship between human development and disappearance of unusually large von Willebrand factor multimers from plasma. , 1989, Blood.

[8]  J. Moake,et al.  Fetal and neonatal von Willebrand factor (vWF) is unusually large and similar to the vWF in patients with thrombotic thrombocytopenic purpura , 1989, British journal of haematology.

[9]  J. Batlle,et al.  PROTEOLYTIC DEGRADATION OF VON WILLEBRAND FACTOR AFTER DDAVP ADMINISTRATION IN NORMAL INDIVIDUALS , 1987, Thrombosis and Haemostasis.

[10]  P. Powers,et al.  Development of the human coagulation system in the full-term infant. , 1987, Blood.

[11]  J. Brown,et al.  An ELISA test for the binding of von Willebrand antigen to collagen. , 1986, Thrombosis research.

[12]  H. H. Salem,et al.  Fast migrating protein, immunochemically related to human factor VIII, studied by crossed immunoelectrophoresis in agarose , 1983, British journal of haematology.

[13]  R. Montgomery,et al.  Newborn Factor VIII Complex: Elevated Activities in Term Infants and Alterations in Electrophoretic Mobility Related to Illness and Activated Coagulatio , 1981, British journal of haematology.

[14]  R. Bertina,et al.  Coagulation Factors in the Human Fetus of about 20 Weeks of Gestational Age , 1980, British journal of haematology.

[15]  O. Finnström,et al.  UMBILICAL ARTERY CATHETERIZATION IN NEWBORNS , 1979, Acta paediatrica Scandinavica.

[16]  S. Suzuki.  Blood coagulation and fibrinolysis of the newborn viewed as perinatal factors. I. Blood coagulation and fibrinolysis of the newborn viewed as obstetrical factors , 1977, Journal of perinatal medicine.

[17]  C. Ts'ao,et al.  Function and Ultrastructure of Platelets of Neonates: Enhanced Ristocetin Aggregation of Neonatal Platelets , 1976, British journal of haematology.

[18]  W. Künzer,et al.  [Determination of bleeding time in childhood and its clinical utilization]. , 1974, Die Medizinische Welt.